Accelerate Diagnostics Inc Beta
Was ist das Beta von Accelerate Diagnostics Inc?
Beta von Accelerate Diagnostics Inc ist 0.32
Was ist die Definition von Beta?
BETA gibt an, ob eine Aktie mehr oder weniger schwankungsanfällig ist als der Gesamtmarkt. Ein Beta von weniger als 1 zeigt an, dass die Aktie weniger schwankungsanfällig ist als der Markt, während ein Beta von mehr als 1 anzeigt, dass die Aktie mehr schwankungsanfällig ist. Die Schwankungsanfälligkeit wird als Schwankung des Preises um den Mittelwert gemessen.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Accelerate Diagnostics Inc
Was macht Accelerate Diagnostics Inc?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Unternehmen mit beta ähnlich Accelerate Diagnostics Inc
- PSP Swiss Property AG hat Beta von 0.32
- Imagi International hat Beta von 0.32
- China Minsheng Banking hat Beta von 0.32
- BOE Varitronix hat Beta von 0.32
- China Overseas Land & Investment hat Beta von 0.32
- Vogo SA hat Beta von 0.32
- Accelerate Diagnostics Inc hat Beta von 0.32
- Pimco California Municipal Income Fund II hat Beta von 0.32
- Get Nice hat Beta von 0.32
- Dierig AG hat Beta von 0.32
- Sunlight Tech Hldg Ltd hat Beta von 0.32
- Sunlight Technology hat Beta von 0.32
- Whitehaven Coal hat Beta von 0.32